Stocklytics Platform
Asset logo for symbol PEN
Penumbra
PEN64
$233.30arrow_drop_up1.92%$4.40
Asset logo for symbol PEN
PEN64

$233.30

arrow_drop_up1.92%
Key Stats
Open$231.08
Prev. Close$228.87
EPS0.86
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range221.77
236.77
52 Week Range148.00
277.34
Ratios
EPS0.86
Fundamentals
Payout Ratio-
Industry average yield2.94%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PEN-
US Healthcare Sector-
US Market-
check_circle

PEN / Market

PEN exceeded the US Market which returned 0.39% over the last twenty four hours.
warning

PEN / Healthcare Sector

PEN lose to the US Healthcare sector which returned 3.96% over the last twenty four hours.

Penumbra (PEN) Statistics

Penumbra Inc (PEN) is a company that specializes in innovative medical devices for the treatment of vascular and neurovascular diseases. The company is known for its cutting-edge technologies and commitment to improving patient care. As of the latest valuation metrics, Penumbra Inc's market capitalization stands at $8.5 billion, making it one of the leading players in the industry. With a strong focus on research and development, the company aims to address unmet medical needs and enhance clinical outcomes.
When it comes to fundamentals, Penumbra Inc has shown remarkable growth and stability over the years. The company's revenue per share has been consistently increasing, indicating strong top-line performance. Additionally, Penumbra Inc's enterprise to EBITDA ratio highlights its ability to generate substantial cash flow from its operations. This financial metric demonstrates the company's efficiency in utilizing its assets to generate profits.
add Penumbra  to watchlist

Keep an eye on Penumbra

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Penumbra (PEN) stock's performance compared to its sector and the market over the past year?

Over the past year, Penumbra (PEN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 31.06%, Penumbra has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 72.87%, it has fallen short of the market average. This comparison highlights Penumbra 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Penumbra (PEN) stock?

The PE (Price to Earnings) ratio of Penumbra (PEN) is currently 271.28. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Penumbra (PEN) stock?

The Earnings Per Share (EPS) for Penumbra (PEN), calculated on a diluted basis, is $0.86. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Penumbra (PEN) stock?

The operating margin for Penumbra (PEN) is 11.75%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Penumbra (PEN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Penumbra (PEN) is $102.64M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Penumbra (PEN) have?

Penumbra (PEN) has a total debt of $226.69M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$53.79M.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level